US Broker Ratings

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with a 7.18% Potential Upside

Abbott Laboratories (NYSE: ABT), a cornerstone in the healthcare sector, continues to capture investor attention with its robust market presence and diversified portfolio. Based in North Chicago, Illinois, this medical..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating Growth Amid a Peak Price

HCA Healthcare, Inc. (NYSE: HCA), a titan in the medical care facilities industry, has recently caught the eye of investors as its stock price reached the upper bound of its..

Zoetis Inc. (ZTS) Stock Analysis: A Look at Its 24% Potential Upside

Zoetis Inc. (NYSE: ZTS), a leader in animal health solutions, offers a compelling investment opportunity with a substantial 24.11% potential upside, according to analyst projections. With a market capitalization of..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A 14.46% Potential Upside with a Robust Dividend Yield

Takeda Pharmaceutical Company Limited (NYSE: TAK), recognized globally for its extensive pharmaceutical portfolio, stands as a compelling opportunity in the healthcare sector. Headquartered in Tokyo, Japan, Takeda is a notable..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a Potential 8.39% Upside

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices sector, is capturing investor attention with a potential upside of 8.39% based on current price targets. Specializing in advanced..

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with Strong Revenue Growth and Robust Dividend Yield

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, stands as a formidable player with a market capitalization of $429.72 billion. As one of the most recognizable names..

AbbVie Inc. (ABBV) Stock Analysis: Evaluating Potential Amidst Healthcare Dominance

AbbVie Inc. (NYSE: ABBV) stands as a titan in the healthcare sector, with its robust market capitalization of $375.5 billion underscoring its significant influence in the drug manufacturing industry. As..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: A 59% Potential Upside Beckons Investors in the Regenerative Medicine Market

Organogenesis Holdings Inc. (NASDAQ: ORGO), a leader in the regenerative medicine sector, is capturing investor attention with its significant potential upside of 59%. With advanced wound care and surgical solutions,..

Standard BioTools Inc. (LAB) Investor Outlook: Exploring a 37.60% Potential Upside in the Healthcare Sector

Standard BioTools Inc. (NASDAQ: LAB), a player in the healthcare sector under the medical devices industry, offers investors a compelling opportunity with its potential upside of 37.60% based on the..

Celcuity Inc. (CELC) Stock Analysis: Strong Buy Ratings and a Promising 27% Upside

In the dynamic landscape of biotechnology, Celcuity Inc. (CELC) stands out as a compelling investment opportunity. With a market capitalization of $2.31 billion, this Minneapolis-based clinical-stage biotechnology company is making..

MeiraGTx Holdings plc (MGTX): Investor Outlook with a 254% Potential Upside

MeiraGTx Holdings plc (NASDAQ: MGTX) is making waves in the biotechnology sector with its promising pipeline of gene therapies targeting serious diseases. With a market cap of $621.05 million and..

Personalis, Inc. (PSNL) Stock Analysis: Assessing a 38.75% Potential Upside in the Diagnostics Sector

Investors eyeing the healthcare sector, particularly those interested in the diagnostics and research industry, should take a closer look at Personalis, Inc. (NASDAQ: PSNL). With a market capitalization of $451.37..

Tourmaline Bio, Inc. (TRML) Stock Analysis: 123.90% Potential Upside Sparks Investor Interest

Tourmaline Bio, Inc. (NASDAQ: TRML) has captured the attention of investors with its promising focus on developing innovative treatments for autoimmune and inflammatory diseases. As a clinical-stage biotechnology company, Tourmaline..

SIGA Technologies Inc. (SIGA) Stock Analysis: Evaluating the 271.90% Revenue Growth Amidst Market Challenges

SIGA Technologies Inc. (SIGA), a key player in the healthcare sector, is making significant strides in the drug manufacturing industry, specifically in the specialty and generic drug space. With a..

Kamada Ltd. (KMDA) Stock Analysis: A Promising Healthcare Play with Nearly 100% Upside Potential

For investors with a keen eye on the healthcare sector, Kamada Ltd. (KMDA), a pivotal player in the drug manufacturing industry, presents an intriguing opportunity. Based in Israel, Kamada Ltd...

Tilray Brands, Inc. (TLRY) Stock Analysis: Navigating the Cannabis Market with Caution Amidst a 19.17 Forward P/E

Tilray Brands, Inc. (NASDAQ: TLRY) remains a focal point in the burgeoning cannabis sector, offering investors a unique blend of opportunities and challenges. As a lifestyle consumer products company, Tilray..

COMPASS Pathways Plc (CMPS) Stock Analysis: Unpacking a 192% Potential Upside in Mental Health Innovation

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering company in the mental health sector, is capturing investor attention with its promising therapeutic developments and a staggering potential upside of 192.16%. With..

Orthofix Medical Inc. (OFIX) Stock Analysis: A 53% Potential Upside Beckons Investors

Orthofix Medical Inc. (NASDAQ: OFIX), a notable player in the medical devices sector, has captured investor attention with a promising potential upside of 53.40%. Specializing in innovative solutions within the..

Semler Scientific (SMLR) Stock Analysis: Unveiling a Potential 203.79% Upside with Strong Buy Ratings

Semler Scientific, Inc. (NASDAQ: SMLR), a key player in the healthcare sector’s medical devices industry, is grabbing investor attention with a tantalizing potential upside of 203.79%. This impressive figure emerges..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds